NCT00467194View on ClinicalTrials.gov

Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

May 31, 2011

Conditions
Liver Cancer
Interventions
DRUG

Rapamycin

DRUG

Bevacizumab

Trial Locations (2)

169610

National Cancer Centre - Singapore, Singapore

308433

Johns Hopkins Singapore International Medical Centre, Singapore

All Listed Sponsors
lead

National Cancer Centre, Singapore

OTHER

NCT00467194 - Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery | Biotech Hunter | Biotech Hunter